Effects of Oral Liposomal Glutathione in Altering the Immune Responses Against Mycobacterium tuberculosis and the Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes
The World Health Organization (WHO) has identified type 2 diabetes (T2DM) as a neglected, important, and re-emerging risk factor for tuberculosis (TB), especially in low and middle-income countries where TB is endemic. In this clinical trial study, oral liposomal glutathione supplementation (L-GSH)...
Main Authors: | Kimberly To, Ruoqiong Cao, Aram Yegiazaryan, James Owens, Timothy Nguyen, Kayvan Sasaninia, Charles Vaughn, Mohkam Singh, Edward Truong, Albert Medina, Edith Avitia, Jose Villegas, Christal Pham, Airani Sathananthan, Vishwanath Venketaraman |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2021.657775/full |
Similar Items
-
The Effects of Oral Liposomal Glutathione and In Vitro Everolimus in Altering the Immune Responses against Mycobacterium bovis BCG Strain in Individuals with Type 2 Diabetes
by: To Kimberly, et al.
Published: (2021-05-01) -
General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus
by: Kimberly To, et al.
Published: (2020-08-01) -
Understanding the Relationship between Glutathione, TGF-β, and Vitamin D in Combating <i>Mycobacterium tuberculosis</i> Infections
by: Mohkam Singh, et al.
Published: (2020-08-01) -
Effects of Glutathione Diminishment on the Immune Responses against <i>Mycobacterium tuberculosis</i> Infection
by: Ruoqiong Cao, et al.
Published: (2021-09-01) -
Review of the Effectiveness of Various Adjuvant Therapies in Treating <i>Mycobacterium tuberculosis</i>
by: Arman Amin, et al.
Published: (2021-09-01)